Vedanta Ltd. Reports Highest-Ever 1H EBITDA at $2.47 Billion
Reading Time: 2 minutes Indian multinational, Vedanta Limited (“Vedanta”) (NSE: VEDL), world’s leading critical and future minerals, energy and technology conglomerate announced its results for Q2 and H1 ending September 30, 2024. It reported highest-ever 1H EBITDA at $2.47 billion, up 46% YoY1. The company’s Q2 consolidated revenue was $4.4
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (08.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 11 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 8 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding
Megaport Launches in Brazil, Bringing Industry-Leading Global Network to South America
Reading Time: 3 minutes Brisbane, Australia: Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, announces its official expansion into Brazil, establishing its connectivity services in São Paulo. This expansion enables enterprises to securely connect locally and globally between 860+
Norconsult ASA: Settlement of Employee Share Program 2023 (“Gift Shares”)
Reading Time: 4 minutes Sandvika, 11 November 2024 (OSE: NORCO): Reference is made to the announcement by Norconsult ASA (the “Company”) regarding the Employee Share Program (the “Share Program”) described in the announcement from 10 November 2023 in connection with the Company’s first day of
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Reading Time: 3 minutes Beijing, China & South San Francisco, Calif., United States: IDEAYA has exercised the option for an exclusive worldwide license on Biocytogen’s potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate (BsADC), BCG034 (IDE034) This milestone further validates Biocytogen’s proprietary RenLite® antibody
What Trends Determine iGaming in 2025? Insights from SOFTSWISS Report
Reading Time: 3 minutes What technologies reshape the future of iGaming? Which business models will ensure growth for the companies? SOFTSWISS, a leading tech company with over 15 years of experience in iGaming, shares its much anticipated new iGaming Trends 2025 Report. The new edition
TDK Ventures Announces Investment Team for Its India Innovation-Hub Location
Reading Time: 4 minutes San Jose, Calif., United States & Bangalore, Karnataka, India: TDK Ventures’ India presence seeks to identify and scale the impact of the country’s extraordinary entrepreneurs and help accelerate their vision for energy, environmental, and digital transformation Tech entrepreneur and
Pihlajalinna Plc: Managers’ transactions – Pihlajalinna Oyj
Reading Time: < 1 minute Pihlajalinna Plc Managers’ transactions 11 November 2024 at 3:00 p.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 11 November 2024: Person subject to the notification requirementName: Anu KallioPosition: Other senior manager Issuer: Pihlajalinna OyjLEI: 74370058MTRLEDOCHV67
Joyville Shapoorji Housing Hosts an Electrifying Performance of Sukhwinder Singh Live Concert at SP Kingstown, Pune
Reading Time: 2 minutes Joyville Shapoorji Housing, an aspirational housing platform by Shapoorji Pallonji, Actis, ADB, and IFC, successfully hosted an unforgettable evening with a sensational live performance by renowned playback singer Sukhwinder Singh. The live concert was held at Joyville Hadapsar Annexe at SP Kingstown, located on the
S&P confirms Balder’s credit rating BBB and changes the outlook from negative to stable
Reading Time: < 1 minute On 11 November S&P announced that they confirm Balder’s credit rating BBB and changes the rating outlook from negative to stable. A stable investment grade rating is important considering Balder’s strategy of having a broad funding base at a favourable